Terumo BCT Inc.
Lakewood, CO Doing business as Caridianbct Inc.
- UEI
- WCEMNMCYNBW1
- CAGE
- 1VBG2
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Garching bei München, BY H1EKCN5SW8P9
-
- SAM.gov registration date
- Physical address
- 10811 Collins Ave, Lakewood, CO 80215, USA
- Website
- terumobct.com
- Founded
- 1964
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $15,869 |
| FY2026 | $806,117 |
| FY2025 | $1,176,538 |
| FY2024 | $1,373,877 |
| FY2023 | $1,535,705 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $671,598 | |
| 2 | Department of Veterans Affairs | $140,080 | |
| 3 | Department of Health and Human Services | $11,542 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fenwal, Inc. | Lake Zurich, IL | 339112 Surgical and Medical Instrument Manufacturing |
| Haemonetics Corporation | Boston, MA | 339112 Surgical and Medical Instrument Manufacturing |
| Nanoentek America, Inc. | Waltham, MA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Grifols Diagnostic Solutions Inc. | Emeryville, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Miltenyi Biotec, Inc. | Auburn, CA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Terumo BCT Inc., operating as the Terumo Bct, Inc. Division and doing business as Caridianbct Inc., manufactures specialized blood and cell processing equipment, sterile consumables, and maintenance services for federal healthcare agencies as a foreign-owned prime contractor (100% of recent awards). The company is based in Lakewood, Colorado and operates as a for-profit manufacturer with primary NAICS concentration in Surgical and Medical Instrument Manufacturing (490 of 995 awards) and In-Vitro Diagnostic Substance Manufacturing (98 awards), predominantly under full-and-open competitive procedures with no set-aside designations.
Terumo BCT's federal footprint centers on medical device supply and maintenance. Representative prime work includes a $407.9 thousand purchase order from the Defense Health Agency for five automated apheresis equipment units (July 2026), a $203.8 million firm fixed-price contract with the Defense Health Agency for annual maintenance and repair of medical equipment at Bethesda, Maryland through January 2028, a $188.7 thousand order from Veterans Integrated Service Network 9 for Spectra Optia apheresis systems and blood warmers (May 2025), and a $230.9 thousand purchase order from the National Institute of Allergy and Infectious Diseases for ten sterile tubing welders to support vaccine research at the Vaccine Research Center (July 2023). The company supplies Spectra Optia apheresis machines, Trima Accel blood cell processors, COBE cell processors, sterile tubing welders (TSCD II and SCD IIB models), blood bag systems (Quad CPD-Optisol sets), and preventative maintenance and repair services across defense and civilian health research agencies. Consumables and equipment are sourced from Terumo BCT's Lakewood manufacturing facility and deployed to customer facilities including Bethesda, Maryland; Denver, Colorado; Portsmouth, Virginia; San Diego, California; and military medical treatment facilities worldwide.
Customer concentration splits between defense and civilian health agencies. The Defense Health Agency anchors the dollars (86 awards, $24.2 million combined potential value), followed by the Department of the Navy Bureau of Medicine and Surgery (175 awards, $23 million combined potential value) and the Department of the Army Medical Command (110 awards, $20.9 million combined potential value). These three customers represent 371 awards and account for approximately 86% of combined potential value across the vendor's active portfolio. The Defense Logistics Agency Troop Support Medical leads by volume (273 awards, $707 thousand combined potential value), reflecting high-frequency, low-dollar blood collection and medical consumables replenishment orders. The National Institutes of Health Clinical Center (52 awards, $2.6 million combined potential value) and the National Cancer Institute represent civilian research agency customers. Together, the top five funding agencies cover 70% of the award count across a 30-agency customer base.
Terumo BCT places work under multiple defense health IDVs and BPAs. The top parent vehicles include Indefinite Delivery Contract N6264509D5015 (36 task orders, $862 thousand combined potential value), Indefinite Delivery Contract N6264513D5049 (19 task orders, $930 thousand combined potential value), Indefinite Delivery Contract N6264519D5002 (16 task orders, $652 thousand combined potential value), Blanket Purchase Agreement W81XWH16A0009 (16 task orders, $104 thousand combined potential value), and Blanket Purchase Agreement HT001420A0013 (11 task orders, $2.1 million combined potential value). Collectively, these vehicles anchor a significant portion of recurring task order activity with defense medical customers.
Activity has declined year over year — seventeen awards in 2022, declining to four awards in 2026 — a trajectory driven primarily by the shift from high-frequency purchase orders to multi-year service and maintenance contracts with extended completion dates. Sixteen awards (combined potential value $1.3 million) face ultimate completion inside the next twenty-four months and therefore carry recompete exposure. The vendor holds no federal contract sub-awards in the source data; all work is performed as a prime contractor. Terumo BCT operates through a named subsidiary, Terumo BCT Europe NV, Deutsche Zweigniederlassung, a foreign-owned for-profit organization, reflecting its parent organization's European manufacturing and distribution footprint.
Quick answers
Is Terumo BCT Inc. registered in SAM.gov?
Yes. Terumo BCT Inc.'s SAM.gov registration is active through March 6, 2027.
How much has Terumo BCT Inc. received in federal contracts?
Federal contracts obligated $1,176,538 to Terumo BCT Inc. in fiscal year 2025 and $4,908,107 in fiscal years 2023 through 2027.
How does Terumo BCT Inc. rank among federal contractors?
Terumo BCT Inc. ranked #86 in NAICS 325413 in FY2025.
What is Terumo BCT Inc.'s most recent federal award?
Terumo BCT Inc.'s most recent federal contract award is A one-year preventive maintenance service agreement covering two spectra optia apheresis systems (SN 1P04813 and SN… (75N98027P00034), from Office of Logisitics and Acquisition Operations (NIH), on December 15, 2026.
On GovTribe
See Terumo BCT Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors